Joni Van der Meulen
Overview
Explore the profile of Joni Van der Meulen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Volders P, Aftimos P, Dedeurwaerdere F, Martens G, Canon J, Beniuga G, et al.
NPJ Precis Oncol
. 2025 Mar;
9(1):66.
PMID: 40065106
The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) study assessed the feasibility of using comprehensive genomic profiling (CGP) in clinical decision-making for patients with advanced cancers. This multi-center...
2.
Donati M, Goutas D, Pissaloux D, Olivares S, Kervarrec T, Nosek D, et al.
Mod Pathol
. 2025 Feb;
:100740.
PMID: 39986469
RET-fused Spitz neoplasms are rare and poorly characterized. We describe clinical, histologic and molecular findings of 31 Spitz neoplasms with RET fusion diagnosed as 16 Spitz nevus (SN), 13 atypical...
3.
Froyen G, Volders P, Geerdens E, Berden S, Van der Meulen J, De Cock A, et al.
Mol Oncol
. 2025 Jan;
PMID: 39887903
Somatic multigene analysis by next-generation sequencing (NGS) is routinely integrated in medical oncology for clinical decision-making. However, with the fast-growing number of recommended and required genes as well as pan-cancer...
4.
Cordier F, Ferdinande L, Loontiens S, Van der Meulen J, Van Dorpe J, Creytens D
Genes Chromosomes Cancer
. 2024 Dec;
63(12):e70016.
PMID: 39636090
No abstract available.
5.
Fieuws C, Van der Meulen J, Proesmans K, De Jaeghere E, Loontiens S, Van Dorpe J, et al.
NPJ Precis Oncol
. 2024 Mar;
8(1):71.
PMID: 38519644
Ovarian cancer is the most lethal gynecologic malignancy, mainly due to late-stage diagnosis, frequent recurrences, and eventually therapy resistance. To identify potentially actionable genetic variants, sequencing data of 351 Belgian...
6.
Deolet E, Cordier F, Ferdinande L, Loontiens S, Van der Meulen J, Van Dorpe J, et al.
Genes Chromosomes Cancer
. 2024 Mar;
63(2):e23225.
PMID: 38470300
No abstract available.
7.
Cordier F, Fadaei S, Ferdinande L, Dochy F, Vanwalleghem L, Van Den Bossche K, et al.
J Clin Pathol
. 2023 Dec;
78(3):154-160.
PMID: 38154915
Aims: -rearranged mesenchymal tumours are a recently identified and rare subgroup of soft tissue neoplasms with distinct morphological features and genetic alterations. This study aims to further investigate the immunohistochemical...
8.
Stelloo E, Meijers R, Swennenhuis J, Allahyar A, Hajo K, Cangiano M, et al.
J Mol Diagn
. 2023 Jul;
25(10):758-770.
PMID: 37517473
Chromosomal rearrangements are important drivers in cancer, and their robust detection is essential for diagnosis, prognosis, and treatment selection, particularly for bone and soft tissue tumors. Current diagnostic methods are...
9.
Cordier F, Loontiens S, Van der Meulen J, Lapeire L, van Ramshorst G, Sys G, et al.
Int J Surg Pathol
. 2023 May;
32(1):133-139.
PMID: 37141633
We report an exceptional case of a spindle cell mesenchymal tumor with S100 and CD34 co-reactivity, which harbored a fusion. To the best of our knowledge, this is the second...
10.
Beyens A, Lietaer C, Claes K, De Baere E, Goeteyn M, Lerut B, et al.
Clin Genet
. 2023 Mar;
103(6):709-713.
PMID: 36896710
Epidermal nevus syndrome (ENS) comprises a heterogeneous group of neurocutaneous syndromes associated with the presence of epidermal nevi and variable extracutaneous manifestations. Postzygotic activating HRAS pathogenic variants were previously identified...